TCF4 rs9960767 genotype | CC + AC | AA | Total | F | df/dferr | p | da | ηp2 |
---|---|---|---|---|---|---|---|---|
n | 11 (10.5%) | 94 (89.5%) | 105 (100%) | |||||
Age | 34.0 (4.1) | 31.6 (1.0) | 31.9 (1.0) | 0.55 | 1/104 | 0.46 | 0.24 | 0.01 |
Years of education | 13.4 (0.7) | 14.8 (0.3) | 14.6 (0.3) | 2.28 | 1/104 | 0.13 | 0.48 | 0.02 |
Men (%)b | 45.5% | 63.8% | 61.9% | — | 1 | 0.33 | — | — |
Current smokers (%)b | 63.6% | 45.7% | 47.6% | — | 1 | 0.34 | — | — |
High-risk subjects (%)b | 45.5% | 34.0% | 35.2% | — | 1 | 0.51 | — | — |
Medication status (%; never-medicated/typical/atypical antipsychotic)b | 45.5/9.1/45.5% | 47.9/10.6/41.5% | 47.6/10.5/41.9% | — | 2 | 0.97 | — | — |
Daily chlorpromazine equivalentsc | 205 (64.0) | 166 (23.0) | 171 (21.6) | 0.32 | 1/104 | 0.57 | 0.18 | 0.00 |
PANSS Positive | 16.3 (2.3) | 15.5 (0.9) | 15.6 (0.8) | 0.09 | 1/104 | 0.76 | 0.10 | 0.00 |
PANSS Negative | 18.8 (3.0) | 17.9 (0.9) | 17.9 (0.8) | 0.11 | 1/104 | 0.75 | 0.11 | 0.00 |
PANSS General | 36.8 (4.8) | 36.8 (1.5) | 36.8 (1.4) | 0.00 | 1/104 | 1.00 | 0.00 | 0.00 |
PANSS Total | 71.9 (9.6) | 70.6 (2.9) | 70.7 (2.8) | 0.02 | 1/104 | 0.89 | 0.05 | 0.00 |
First block, amplitude of pulse-alone trials (arbitrary units) | 384 (74.9) | 306 (21.0) | 314 (20.3) | 1.38 | 1/104 | 0.24 | 0.37 | 0.01 |
Mean amplitude of pulse-alone trials (arbitrary units) | 291 (64.1) | 232 (18.7) | 238 (18.0) | 1.00 | 1/104 | 0.32 | 0.32 | 0.01 |
Mean percentage PPI (SOA 120 ms)d | 25.0% (8.4) | 45.2% (2.9) | 42.6% (2.7) | 5.13 | 1/100 | 0.03 | 0.73 | 0.05 |
Percentage early habituation of pulse-alone trials (between first and second block) | 24.8% (4.4) | 22.3% (3.1) | 22.6% (2.8) | 0.07 | 1/104 | 0.79 | 0.09 | 0.00 |
Percentage total habituation of pulse-alone trials (between first and sixth block) | 32.9% (7.6) | 42.1% (3.0) | 41.1% (2.8) | 1.06 | 1/104 | 0.31 | 0.33 | 0.01 |
Habituation of pulse-alone trials across 6 blocks (linear gradient coefficient b) | −19.1 (5.1) | −20.1 (1.9) | −20.0 (1.8) | 0.03 | 1/104 | 0.86 | 0.05 | 0.00 |
Bold indicates statistical significance.
↵aEffect size Cohen's d (d = 0.2 is small, d = 0.5 is moderate, and d = 0.8 is a strong effect).
↵bFisher's exact test.
↵cUnmedicated patients and high-risk individuals received the value 0.
↵dANCOVA, means adjusted by covariates sex, medication (medicated/unmedicated), and smoking status (yes/no).